Cohen Fred E
SEC CIK 1339358 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CDNA | CareDx, Inc. | Dir | 165.1K | — | — | 7 | 2022-06-16 | 2026-06-12 |
| NTLA | Intellia Therapeutics, Inc. | Dir | 216.7K | $1.40M | — | 6 | 2022-06-14 | 2026-06-09 |
| KYTX | Kyverna Therapeutics, Inc. | Dir, 10% | 21.7K | — | — | 3 | 2024-02-12 | 2026-05-27 |
| PGNY | Progyny, Inc. | Dir | 22.7K | — | — | 4 | 2021-10-24 | 2024-05-23 |
| URGN | UroGen Pharma Ltd. | Dir | 69.3K | — | — | 1 | 2023-07-26 | 2023-07-26 |
Most active insiders at CDNA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Hanna John Walter JR | Pres, CEO, Dir | — | $7.54M |
| 2 | Goldberg Michael | Dir | — | $2.10M |
| 3 | Valantine Hannah | Dir | — | $1.32M |
| 4 | Bickerstaff George | Dir | — | $925.7K |
| 5 | COURNOYER CHRISTINE | Dir | — | $751.0K |
| 6 | Novack Jeffrey Adam | GC, Sec | — | $452.8K |
| 7 | TORRES ARTHUR A | Dir | — | $214.7K |
| 8 | Gunasekaran Suresh | Dir | — | — |
| 9 | SMITH NATHAN | CFO | — | — |
| 10 | Meng Jessica | Chief Commercial Off | — | — |
| 13 | Cohen Fred E | Dir | — | — |
Transactions 21
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-06-16 17:49 | 2026-06-12 | CDNA | CareDx, Inc. | Cohen Fred E | Dir | A - Grant | $0.00 | +9,795 | 165.1K | +6% | $0 |
| D | 2026-06-10 19:01 | 2026-06-09 | NTLA | Intellia Therapeutics, Inc. | Cohen Fred E | Dir | A - Grant | $0.00 | +9,200 | 216.7K | +4% | $0 |
| D | 2026-05-29 16:30 | 2026-05-27 | KYTX | Kyverna Therapeutics, Inc. | Cohen Fred E | Dir | A - Grant | $0.00 | +5,093 | 21.7K | +31% | $0 |
| 2026-01-07 | 2026-01-05 | NTLA | Intellia Therapeutics, Inc. | Cohen Fred E | Dir | P - Purchase | $9.35 | +150.0K | 207.5K | +261% | +$1.40M | |
| 2025-06-17 | 2025-06-13 | CDNA | CareDx, Inc. | Cohen Fred E | Dir | A - Grant | $0.00 | +12.1K | 155.3K | +8% | $0 | |
| D | 2025-06-13 | 2025-06-11 | NTLA | Intellia Therapeutics, Inc. | Cohen Fred E | Dir | A - Grant | $0.00 | +8,000 | 57.5K | +16% | $0 |
| D | 2025-06-02 | 2025-05-29 | KYTX | Kyverna Therapeutics, Inc. | Cohen Fred E | Dir, 10% | A - Grant | $0.00 | +16.6K | 16.6K | New | $0 |
| D | 2024-06-18 | 2024-06-14 | CDNA | CareDx, Inc. | Cohen Fred E | Dir | A - Grant | $0.00 | +10.6K | 143.2K | +8% | $0 |
| D | 2024-06-14 | 2024-06-12 | NTLA | Intellia Therapeutics, Inc. | Cohen Fred E | Dir | A - Grant | $0.00 | +7,737 | 49.5K | +19% | $0 |
| D | 2024-05-28 | 2024-05-23 | PGNY | Progyny, Inc. | Cohen Fred E | Dir | A - Grant | $0.00 | +6,176 | 22.7K | +37% | $0 |
| DI | 2024-02-14 | 2024-02-12 | KYTX | Kyverna Therapeutics, Inc. | Cohen Fred E | Dir, 10% | C - Cnv Deriv | — | +4.52M | 4.52M | New | — |
| I | 2023-07-28 | 2023-07-26 | URGN | UroGen Pharma Ltd. | Cohen Fred E | Dir | A - Grant | $9.54 | +69.3K | 69.3K | New | +$661.5K |
| D | 2023-06-21 | 2023-06-16 | CDNA | CareDx, Inc. | Cohen Fred E | Dir | A - Grant | $0.00 | +18.8K | 132.6K | +17% | $0 |
| D | 2023-06-16 | 2023-06-14 | NTLA | Intellia Therapeutics, Inc. | Cohen Fred E | Dir | A - Grant | $0.00 | +4,425 | 41.7K | +12% | $0 |
| D | 2023-05-26 | 2023-05-24 | PGNY | Progyny, Inc. | Cohen Fred E | Dir | A - Grant | $0.00 | +4,385 | 16.5K | +36% | $0 |
| 2023-01-09 | 2023-01-06 | CDNA | CareDx, Inc. | Cohen Fred E | Dir | A - Grant | $0.00 | +1,062 | 113.7K | +0.9% | $0 | |
| D | 2022-10-26 | 2022-10-24 | PGNY | Progyny, Inc. | Cohen Fred E | Dir | A - Grant | $0.00 | +3,480 | 12.1K | +40% | $0 |
| 2022-10-04 | 2022-10-04 | CDNA | CareDx, Inc. | Cohen Fred E | Dir | A - Grant | $0.00 | +803 | 112.7K | +0.7% | $0 | |
| D | 2022-06-21 | 2022-06-16 | CDNA | CareDx, Inc. | Cohen Fred E | Dir | A - Grant | $0.00 | +4,863 | 111.9K | +5% | $0 |
| D | 2022-06-16 | 2022-06-14 | NTLA | Intellia Therapeutics, Inc. | Cohen Fred E | Dir | A - Grant | $0.00 | +5,197 | 37.3K | +16% | $0 |
| D | 2021-10-26 | 2021-10-24 | PGNY | Progyny, Inc. | Cohen Fred E | Dir | A - Grant | $0.00 | +2,652 | 8,652 | +44% | $0 |
Purchase Sale Sale after option exercise All abbreviations